Multiple myeloma is a malignant disease characterised by proliferation of clonal plasma cells in the bone marrow and typically accompanied by the secretion of monoclonal immunoglobulins that are detectable in the serum or ...
Jan 20, 2015
0
5
Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer Institute have found in ...
Dec 8, 2014
0
0
Patients with plasma cell dyscrasis have high amounts of an abnormal immunoglobulin, called a paraprotein, in their blood. While many patients have no outward symptoms, paraproteins can impair immune function, thicken blood, ...
Dec 8, 2014
0
0
The "molecular mail" sent by multiple myeloma cells provides clues to how well patients with the disease are likely to respond to treatment, according to a study being presented at the annual meeting of the American Society ...
Dec 7, 2014
0
0
In the treatment of multiple myeloma, the addition of carfilzomib to a currently accepted two-drug combination produced significantly better results than using the two drugs alone, according to a worldwide research team led ...
Dec 6, 2014
0
0
The investigational drug ixazomib taken orally in combination with lenalidomide and dexamethasone shows promise in patients with newly diagnosed multiple myeloma, according to the results of a phase 1/2 study published in ...
Nov 17, 2014
0
0
(HealthDay)—Health-related quality of life (HRQOL) is worse for older survivors of selected cancers, specifically survivors of multiple myeloma and pancreatic cancer, according to a study published online Nov. 4 in Cancer.
Nov 11, 2014
0
0
The International Myeloma Working Group (IMWG) today announced that it has updated the criteria for diagnosing multiple myeloma. A paper outlining the new criteria was published in the journal Lancet Oncology. Multiple myeloma ...
Oct 27, 2014
0
0
Scientists at Imperial College London have developed a new cancer drug which they plan to trial in multiple myeloma patients by the end of next year.
Oct 13, 2014
2
0
In an advance against the problem of cancer metastasis, Dana-Farber Cancer Institute scientists have shown that a specially developed compound can impede multiple myeloma from spreading to the bones in mice. The findings, ...
Sep 25, 2014
0
0
